Acute limb ischemia is a vascular emergency defined as a sudden decrease in limb perfusion (symptoms <2 weeks) that threatens limb viability, with an incidence of approximately 1.5 per 10,000 persons per year and mortality/amputation rates up to 15%. [1-2] Skeletal muscle tolerates ischemia for only 4–6 hours, making rapid recognition and treatment critical. [3]
The following figure illustrates the Rutherford classification system and management algorithm for ALI:
1. History
- Onset and timing: Sudden vs. subacute onset; symptoms <2 weeks define ALI. Embolic events tend to be abrupt ("thunderclap"), while in situ thrombosis may present more gradually over hours to days [2]
- The 6 Ps: Pain, pallor, pulselessness, poikilothermia (coolness), paresthesias, paralysis — ask about each systematically [3][5]
- Pain characterization: Location, severity, progression; rest pain vs. exertional. Severe unrelenting pain is typical; pain out of proportion to exam findings is concerning
- Symptom progression: Numbness → weakness → paralysis indicates worsening ischemia and time-critical intervention [3]
- Prior claudication or PAD history: Patients with preexisting PAD may tolerate longer ischemia due to collateralization; those without PAD may decompensate faster [3]
- Recent procedures: Femoral catheterization, vascular interventions, prior bypass grafts or stents [3]
- Cardiac history: Atrial fibrillation, recent MI, cardiomyopathy, valvular disease (embolic sources) [3]
- Medication history: Anticoagulants (and when last taken), antiplatelets, chemotherapy agents [3]
2. Alarm Features
- Motor deficit (foot drop, inability to wiggle toes) → Rutherford IIb, requires immediate revascularization [1]
- Complete sensory loss (anesthetic limb) + paralysis + absent arterial AND venous Doppler signals → Rutherford III (irreversible), nonsalvageable limb [3]
- Muscle rigidity/rigor — late sign indicating tissue necrosis and probable irreversibility [6]
- Mottled, non-blanching skin — suggests advanced ischemia
- Rapidly progressive symptoms — the longer symptoms are present, the less likely limb salvage [3]
- Signs of systemic toxicity post-revascularization: hyperkalemia, metabolic acidosis, myoglobinuria, renal failure (reperfusion syndrome) [2][7]
3. Medications
Acute treatment
- IV unfractionated heparin (UFH): Administer immediately upon suspicion of ALI (Class I recommendation) unless contraindicated — prevents thrombus propagation [3][8]
- Analgesics: Adequate pain control is essential; opioids often required
- Catheter-directed thrombolytics (e.g., tPA, urokinase): For salvageable limbs (Rutherford I, IIa); considered first-line endovascular therapy [3][9]
Post-revascularization
- Continue full-dose heparin drip → transition to oral anticoagulant + antiplatelet (typically aspirin) [1]
- Cardioembolic etiology (e.g., AF): Therapeutic-dose DOAC (e.g., rivaroxaban, apixaban) [1]
- Non-embolic/PAD-related ALI: Short-course DAPT, then long-term aspirin + low-dose rivaroxaban 2.5 mg BID (COMPASS/VOYAGER regimen) [1]
Contraindicated/cautions
- Avoid vasopressors that worsen limb perfusion when possible
- Thrombolysis contraindicated in active bleeding, recent stroke, recent major surgery [9]
- Heparin contraindicated if HIT suspected — use alternative anticoagulant (argatroban, bivalirudin) [3]
4. Diet
- Not directly applicable in the acute setting
- Long-term: Heart-healthy/Mediterranean diet for atherosclerotic risk reduction; smoking cessation is paramount
- Hydration: Aggressive IV hydration is critical post-revascularization to prevent myoglobin-induced renal injury [2][6]
- Alkalinization of urine (IV sodium bicarbonate) may help prevent myoglobin precipitation in renal tubules [6]
5. Review of Systems
- Cardiovascular: Palpitations, irregular heartbeat (AF), chest pain, dyspnea (cardiac embolism source) [3]
- Neurologic: Sensory changes, weakness, numbness in affected limb — critical for Rutherford staging
- Urologic: Dark/tea-colored urine (myoglobinuria post-reperfusion) [6]
- Constitutional: Fever, weight loss (endocarditis, malignancy as embolic sources)
- Contralateral limb: Symptoms suggesting bilateral disease or saddle embolus (aortic bifurcation)
- Asymmetric leg swelling: Consider phlegmasia cerulea dolens (DVT-related ischemia) [2]
6. Collateral History and Family History
- Collateral: Confirm symptom onset time (critical for ischemia duration estimation); medication compliance (anticoagulants); recent hospitalizations or procedures
- Family history: Premature atherosclerotic disease, hypercoagulable states (antiphospholipid syndrome, Factor V Leiden), PAD [3]
- Social context: Smoking history (strongest modifiable PAD risk factor), IV drug use (endocarditis risk), functional baseline
7. Risk Factors
- Underlying PAD — most common cause; rate of ALI in PAD patients is 0.8%–1.7% [3]
- Atrial fibrillation — leading cardiac embolic source [3]
- Prior lower extremity revascularization (bypass graft or stent thrombosis) [3][10]
- Low baseline ABI (≤0.60) [3][10]
- Chronic kidney disease [10]
- Hypercoagulable states: Antiphospholipid syndrome, HIT, cancer-associated thrombosis [3]
- Cancer chemotherapy: Platinum-based agents, tyrosine kinase inhibitors [3]
- Popliteal artery aneurysm — classic cause of distal embolization [3]
- Diabetes, hypertension, dyslipidemia, smoking, age >65 [11]
- COVID-19 and other prothrombotic viral illnesses [3]
8. Differential Diagnosis
- Acute DVT / Phlegmasia cerulea dolens: Massive venous thrombosis causing limb ischemia — distinguished by severe swelling and dusky discoloration rather than pallor [2][12]
- Chronic limb-threatening ischemia (CLTI): Symptoms >2 weeks; preexisting wounds, gangrene; collaterals present [2]
- Aortic dissection with limb malperfusion: Back/chest pain, pulse differential between limbs [3]
- Compartment syndrome (non-vascular): Trauma-related; tense compartments, pain with passive stretch [12]
- Atheroembolism ("trash foot"): Blue toe syndrome, livedo reticularis, preserved pulses [2]
- Vasospasm (ergotism, vasopressors, Raynaud's): Reversible; often bilateral [2]
- Neuropathy: Acute mononeuropathy (e.g., peroneal nerve palsy) — no vascular compromise
- Acute gout, soft tissue injury: Non-ischemic limb pain mimics [2]
9. Past Medical History
- Prior PAD, claudication, or critical limb ischemia
- Previous revascularization (bypass grafts, stents, angioplasty) — high risk for graft/stent thrombosis [3]
- Atrial fibrillation, heart failure, cardiomyopathy, valvular disease
- Prior arterial embolism or DVT/PE
- Hypercoagulable disorders
- Diabetes, CKD, hypertension
- Active malignancy and chemotherapy regimen
- Recent vascular access procedures (catheterization) [3]
10. Physical Exam
Vital signs
Focused limb exam
- Temperature: Cool limb compared to contralateral side
- Color: Pallor, mottling, cyanosis; non-blanching skin = advanced ischemia
- Pulses: Palpate femoral, popliteal, dorsalis pedis, posterior tibial bilaterally — note that pulse palpation is inaccurate in ALI; bedside continuous-wave Doppler is essential [3]
- Sensory testing: Light touch, pinprick — loss limited to toes (IIa) vs. beyond toes (IIb) vs. anesthetic (III) [3]
- Motor testing: Dorsiflexion/plantarflexion of foot and toes — any weakness = at minimum IIb [3]
- Muscle consistency: Soft (viable) vs. tense (compartment syndrome) vs. rigid/woody (irreversible) [6]
- Capillary refill: Prolonged or absent
Cardiac exam
- Irregular rhythm (AF), murmurs (valvular disease, endocarditis)
- Contralateral limb pulses and exam for bilateral disease
11. Lab Studies
- CBC: Baseline; leukocytosis may suggest infection/systemic inflammation
- BMP/CMP: Creatinine (baseline renal function), potassium (hyperkalemia risk post-reperfusion), bicarbonate (metabolic acidosis) [7][13]
- Coagulation studies: PT/INR, aPTT — baseline before heparin; assess anticoagulation status
- Lactate: Elevated in severe ischemia; marker of tissue hypoperfusion
- Creatine kinase (CK): Baseline and serial monitoring; CK >5,000 U/L predicts 50% risk of acute renal failure [6]
- Urine myoglobin: Positive = rhabdomyolysis; >20 mg/dL predictive of renal failure [6]
- Type and screen: Anticipate potential surgical intervention
- Troponin: If cardiac embolism suspected or concurrent ACS
- Hypercoagulability workup (non-emergent): Antiphospholipid antibodies, HIT panel if indicated [3]
12. Imaging
First-line
- Bedside continuous-wave Doppler: Most important initial tool — assess for arterial and venous signals. Loss of arterial signal = threatened limb; loss of both = likely irreversible [3]
- CTA (CT angiography): First-line imaging modality when imaging is pursued; provides vascular anatomy, occlusion location, and surrounding tissue assessment [12][14]
Important caveats
- Per 2024 ACC/AHA guidelines, imaging should NOT delay treatment — clinical assessment alone is sufficient to initiate therapy in most cases (Class 1 recommendation) [3]
- Imaging is most useful in patients with complicated revascularization history or when anatomy is unclear [3]
Other modalities
- Duplex ultrasound: Can assess flow; operator-dependent; useful at bedside
- MRA: Alternative to CTA (avoid in renal failure with gadolinium concerns)
- Conventional angiography: Performed at time of intervention; gold standard for anatomic detail
When imaging is unnecessary
13. Special Tests
Rutherford Classification for ALI — the key clinical staging system: [1][3]
- Ankle-brachial index (ABI): Perfusion pressure <50 mmHg at the ankle indicates limb ischemia [2]
- Compartment pressure measurement: >30 mmHg or within 30 mmHg of diastolic pressure confirms compartment syndrome [2]
- Echocardiography: TTE/TEE to evaluate for cardiac embolic source (LV thrombus, LA appendage thrombus, valvular vegetations) [3]
14. ECG
- Obtain ECG on all ALI patients to evaluate for:
- Atrial fibrillation — most common cardiac embolic source [3]
- Evidence of recent MI (ST changes, Q waves) — LV thrombus risk
- Baseline rhythm before anticoagulation/intervention
- Post-revascularization: Monitor for hyperkalemia from reperfusion injury — peaked T waves → PR prolongation → QRS widening → sine wave → VF/asystole [16-17]
- Hyperkalemia-induced ST elevation can mimic acute MI ("dialyzable currents of injury") [18]
- Continuous telemetry is essential post-revascularization given risk of arrhythmia from metabolic derangements [2]
15. Assessment
Severity stratification is driven by the Rutherford classification (see table above), which determines urgency of intervention: [1][3]
- Category I: Viable — time for workup and imaging
- Category IIa: Marginally threatened — prompt revascularization needed (hours)
- Category IIb: Immediately threatened — emergent revascularization required
- Category III: Irreversible — revascularization is contraindicated; proceed to amputation [3]
Typical presentation: Sudden severe limb pain with pallor, coolness, absent pulses, and sensory changes. Atypical presentations include gradual worsening of claudication (in situ thrombosis on chronic PAD) or painless ischemia in neuropathic patients (diabetics). [2][19]
Complications to anticipate: Compartment syndrome, rhabdomyolysis, acute kidney injury, hyperkalemia, metabolic acidosis, ARDS, cardiac arrhythmias, multi-organ failure, re-thrombosis, amputation. [2][7]
16. Treatment Plan
Initial stabilization (ED)
- IV unfractionated heparin bolus (typically 80 U/kg bolus, then 18 U/kg/hr infusion) — administer immediately unless contraindicated [3][8]
- Aggressive pain management — IV opioids as needed
- Position limb in dependent position (below heart level) to maximize perfusion
- Avoid warming devices (risk of thermal injury to ischemic tissue)
- Emergent vascular surgery/interventional consultation [3]
Revascularization (by Rutherford category)
- Category I/IIa: Catheter-directed thrombolysis is effective first-line therapy; percutaneous mechanical thrombectomy as adjunct [3][9]
- Category IIb: Definitive procedure required — open surgical thromboembolectomy (Fogarty catheter) or endovascular thrombectomy [1][3]
- Category III: No revascularization — primary amputation to avoid lethal reperfusion syndrome [3]
Post-revascularization
- Continue heparin drip → transition to long-term antithrombotic therapy based on etiology [1]
- Fasciotomy: Perform for clinical compartment syndrome; consider prophylactic fasciotomy for Rutherford IIa/IIb or >6 hours of ischemia [1][3]
- Aggressive IV hydration + urine alkalinization for rhabdomyolysis prevention [2][6]
- Serial CK, potassium, creatinine, urine myoglobin monitoring
- Treat hyperkalemia emergently if present (calcium gluconate, insulin/dextrose, kayexalate, dialysis)
17. Disposition
All patients with ALI require admission
- ICU/monitored bed: Rutherford IIb or III; post-revascularization patients; those with reperfusion injury, hemodynamic instability, or metabolic derangements
- Vascular surgery floor: Rutherford I/IIa after successful revascularization with stable exam
Transfer criteria
Specialist consultation triggers
- Vascular surgery — all cases [3]
- Interventional radiology/cardiology — for endovascular approaches
- Cardiology — if cardiac embolic source identified
- Nephrology — if acute kidney injury develops
- Orthopedic surgery — if fasciotomy needed and vascular surgery unavailable
Amputation: Primary amputation for Rutherford III; concurrent amputation may be considered even with revascularization if prolonged severe ischemia with expected lethal reperfusion [3]
18. Follow Up / Return Precautions
Inpatient follow-up
- Serial neurovascular exams (every 1–2 hours post-revascularization)
- Monitor for compartment syndrome for at least 24–48 hours post-reperfusion
- Serial labs: CK, potassium, creatinine, urine output
Post-discharge
- Vascular surgery follow-up within 1–2 weeks
- Duplex ultrasound surveillance of revascularized segment
- Cardiology follow-up if embolic source identified (AF management, echo follow-up)
- Long-term antithrombotic optimization based on etiology [1]
- Aggressive cardiovascular risk factor modification: smoking cessation, statin therapy, blood pressure and glucose control [11]
Return precautions — counsel patients on
- Return immediately for recurrent limb pain, numbness, weakness, color change, or coolness
- Dark/tea-colored urine, decreased urine output
- Chest pain, palpitations, shortness of breath
- Wound complications at surgical/access sites
- Expected recovery: Sensory deficits may persist for weeks to months; motor recovery depends on duration and severity of ischemia
References
1. Antithrombotic Strategies for Patients With Peripheral Artery Disease: JACC Scientific Statement. — Bonaca MP, Barnes GD, Bauersachs R, et al. Journal of the American College of Cardiology. 2024.
2. Acute Limb Ischemia. — Creager MA, Kaufman JA, Conte MS. The New England Journal of Medicine. 2012.
3. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. — Gornik HL, Aronow HD, Goodney PP, et al. Journal of the American College of Cardiology. 2024.
4. The Diagnosis, Evaluation and Contemporary Management of Acute Limb Ischemia. — Michael N. Young, Douglas E. Drachman Endovascular Interventions. 2018.
5. Acute Limb Ischemia Interventions. — Ahmed A, Naeem N, Jain A, Arora S, Elgendy IY. Interventional Cardiology Clinics. 2025.
6. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). — Norgren L, Hiatt WR, Dormandy JA, et al. Journal of Vascular Surgery. 2007.
7. Muscular, Renal, and Metabolic Complications of Acute Arterial Occlusions: Myonephropathic-Metabolic Syndrome. — Haimovici H. Surgery. 1979.
8. ACC/AHA Versus ESC Guidelines for Diagnosis and Management of Peripheral Artery Disease: JACC Guideline Comparison. — Kithcart AP, Beckman JA. Journal of the American College of Cardiology. 2018.
9. Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions. — Rashedi S, Leyva H, Hamade N, et al. Journal of the American College of Cardiology. 2025.
10. Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia: A Review. — Polonsky TS, McDermott MM. The Journal of the American Medical Association. 2021.
11. Management of Lower Extremity Peripheral Artery Disease: Guidelines From the ACC/AHA. — Arnold M. American Family Physician. 2025.
12. ACR Appropriateness Criteria® Sudden Onset of Cold, Painful Leg: 2023 Update. — Browne WF, Sung J, Majdalany BS, et al. Journal of the American College of Radiology : JACR. 2023.
13. Pathophysiology of Acute Arterial Occlusion. — Walker PM. Canadian Journal of Surgery. Journal Canadien De Chirurgie. 1986.
14. High Risk and Low Prevalence Diseases: Acute Limb Ischemia. — Arnold J, Koyfman A, Long B. The American Journal of Emergency Medicine. 2023.
15. ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary a Collaborative Report From the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; And Vascular Disease Foundation. — Hirsch AT, Haskal ZJ, Hertzer NR, et al. Journal of the American College of Cardiology. 2006.
16. Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association. — Sandau KE, Funk M, Auerbach A, et al. Circulation. 2017.
17. Metabolic disturbances for the electrophysiologist. — Lee JZ, Asirvatham SJ. Journal of Cardiovascular Electrophysiology. 2019.
18. ST-Segment Elevation in Conditions Other Than Acute Myocardial Infarction. — Wang K, Asinger RW, Marriott HJ. The New England Journal of Medicine. 2003.
19. Infusion Techniques for Peripheral Arterial Thrombolysis. — Broderick C, Patel JV. The Cochrane Database of Systematic Reviews. 2021.